North China Pharmaceutical Co Ltd banner
N

North China Pharmaceutical Co Ltd
SSE:600812

Watchlist Manager
North China Pharmaceutical Co Ltd
SSE:600812
Watchlist
Price: 5.56 CNY -0.36% Market Closed
Market Cap: ¥9.5B

Wall Street
Price Targets

Price Targets Summary
North China Pharmaceutical Co Ltd

There are no price targets for North China Pharmaceutical Co Ltd.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
North China Pharmaceutical Co Ltd Competitors:
Price Targets
PACB
Pacific Biosciences of California Inc
48% Upside

Revenue
Forecast

-2% / Year
Past Growth
7% / Year
Estimated Growth
Estimates Accuracy
0%
Average Miss
-2% / Year
Past Growth
7% / Year
Estimated Growth
Estimates Accuracy
0%
Average Miss

For the last 13 years the compound annual growth rate for North China Pharmaceutical Co Ltd's revenue is -2%. The projected CAGR for the next 4 years is 7%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

-1% / Year
Past Growth
11% / Year
Estimated Growth
Estimates Accuracy
-60%
Average Miss
-1% / Year
Past Growth
11% / Year
Estimated Growth
Estimates Accuracy
-60%
Average Miss

For the last 13 years the compound annual growth rate for North China Pharmaceutical Co Ltd's net income is -1%. The projected CAGR for the next 4 years is 11%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is North China Pharmaceutical Co Ltd's stock price target?
Not Available

North China Pharmaceutical Co Ltd doesn't have any price targets made by Wall Street professionals.

What is North China Pharmaceutical Co Ltd's Revenue forecast?
Projected CAGR
7%

For the last 13 years the compound annual growth rate for North China Pharmaceutical Co Ltd's revenue is -2%. The projected CAGR for the next 4 years is 7%.

What is North China Pharmaceutical Co Ltd's Net Income forecast?
Projected CAGR
11%

For the last 13 years the compound annual growth rate for North China Pharmaceutical Co Ltd's net income is -1%. The projected CAGR for the next 4 years is 11%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett